Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Buy
425,000
+220,000
+107% +$334K ﹤0.01% 4601
2026
Q1
$371K Buy
+205,000
New +$354K ﹤0.01% 4916

Other funds holding OCGN

Israel Englander's OCGN Position: Q2 2026 in Review

Israel Englander increased its Ocugen (OCGN) stake by 1.6% in Q2 2026, buying an estimated $328K and bringing the position to 13,943,252 shares worth $21.3M. The position accounts for 0.01% of the portfolio, ranked #1565.

Israel Englander first reported a position in OCGN in Q4 2014 and has held it in 24 quarters since. The position peaked at $24.8M in Q1 2026. 146 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Israel Englander held 13,943,252 shares of Ocugen worth $21.3M as of Q2 2026.
  • Israel Englander bought 216,060 Ocugen shares in Q2 2026, an estimated $328K.
  • Ocugen made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1565 holding.
  • Israel Englander first reported a position in Ocugen in Q4 2014 and has held it in 24 quarters since.
  • Israel Englander's Ocugen position peaked at $24.8M in Q1 2026.
  • 146 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.